06.09.2018
SHOP APOTHEKE EUROPE N.V. NL0012044747
DGAP-News: SHOP APOTHEKE EUROPE to be included in SDAX select index.
DGAP-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Miscellaneous
SHOP APOTHEKE EUROPE to be included in SDAX select index.
06.09.2018 / 06:50
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
NOT FOR RELEASE OR DISTRIBUTION IN THE USA, CANADA, AUSTRALIA OR JAPAN.
SHOP APOTHEKE EUROPE to be included in SDAX select index.
* Admission to SDAX effective as of September 24, 2018
* SHOP APOTHEKE EUROPE has been part of MSCI SmallCap Germany since May
31, 2018.
Venlo, the Netherlands, September 6, 2018. SHOP APOTHEKE EUROPE N.V.,
Continental Europe's leading online pharmacy, has been admitted to one of
the DAX group's select indices for the first time ever. The company will
join the SDAX on September 24, 2018, Deutsche Börse announced yesterday.
Since its IPO in October 2016, SHOP APOTHEKE EUROPE has continuously
increased its market capitalization (currently c. EUR 650 million) and share
turnover. These developments are the result of dynamic operational growth in
the sales of non-prescription (OTC) medications and beauty and personal care
products as well as of the company's active role in the consolidation of the
online pharmacy market. Headquartered in Venlo, the Netherlands, the company
is covered by analysts from Berenberg, Citibank, Commerzbank, Deutsche Bank
and Metzler.
"It is great that Shop Apotheke Europe N.V. will be listed in the SDAX,
which further increases investor interest in our dynamic growth story", says
SHOP APOTHEKE EUROPE CFO Dr. Ulrich Wandel. "Being admitted to the SDAX is
also a proof that our successful European growth strategy is on the right
track. Our next goal is to reach 1 billion Euros in revenues."
2018 FINANCE CALENDAR.
24 September Goldman Sachs & Berenberg Conference, Munich
2018
14 November Analysts' conference and publication of Q3 results at
2018 Citibank, London
27 November Berenberg West Coast Conference, San Francisco
2018
3 December Berenberg Pennyhill Conference, London
2018
ABOUT SHOP APOTHEKE EUROPE.
SHOP APOTHEKE EUROPE is the leading and fastest growing online pharmacy in
Continental
Europe. With the acquisition of Europa Apotheek Venlo in November 2017, SHOP
APOTHEKE EUROPE significantly extended its European market leadership with
an expanded product range for the whole family in the areas of OTC, beauty
and personal care products as well as prescription drugs.
SHOP APOTHEKE EUROPE already operates online pharmacies in Germany, Austria,
France, Belgium, Italy, Spain and the Netherlands. In Germany, the
TÜV-certified shop-apotheke.com is the clear market leader. SHOP APOTHEKE
EUROPE delivers a broad range of more than 100,000 original products to over
3 million active customers fast and at attractive prices. In addition, SHOP
APOTHEKE EUROPE provides comprehensive pharmaceutical consulting services.
SHOP APOTHEKE EUROPE N.V. has been listed on the regulated market of the
Frankfurt Stock Exchange (Prime Standard) since 13 October 2016.
MEDIA CONTACTS.
Trade and popular media:
Sven Schirmer
Mobile: +49 152 28 50 63 61
Email: [email protected]
Financial media:
Thomas Schnorrenberg
Mobile +49 151 46 53 13 17
Email: [email protected]
Investor relations:
Dr. Ulrich Wandel
Phone: +31 77 850 6117
Email: [email protected]
DISCLAIMER.
This release contains statements that relate to future business performance
and future financial performance, as well as to events or developments
pertaining to SHOP APOTHEKE EUROPE, and that may constitute forward-looking
statements. These statements are based on current expectations and
assumptions by SHOP APOTHEKE EUROPE's management, a large number of which
are beyond the control of SHOP APOTHEKE EUROPE. They are therefore subject
to a variety of risks and uncertainties. If these risks and uncertainties
materialize, or the underlying expectations do not materialize or the
assumptions made prove incorrect, actual events, both in a positive and
negative sense, may differ materially from those described or implied in the
forward-looking statements. SHOP APOTHEKE EUROPE undertakes no obligation to
update these forward-looking statements or to correct them in any other than
anticipated development. SHOP APOTHEKE EUROPE also does not intend to do so.
---------------------------------------------------------------------------
06.09.2018 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: SHOP APOTHEKE EUROPE N.V.
Dirk Hartogweg 14
5928 LV Venlo
Netherlands
Phone: 0800 - 200 800 300
Fax: 0800 - 90 70 90 20
E-mail: [email protected]
Internet: www.shop-apotheke-europe.com
ISIN: NL0012044747, DE000A19Y072
WKN: A2AR94, A19Y07
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover,
Munich, Stuttgart, Tradegate Exchange
End of News DGAP News Service
---------------------------------------------------------------------------
721051 06.09.2018
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
SHOP APOTHEKE EUROPE N.V. ISIN: NL0012044747 können Sie bei EQS abrufen
E-Commerce , A2AR94 , RDC , XETR:SAE